Stocksigma LogoStocksigma Logo

Wanbury Receives Australian TGA GMP Compliance Certificate for Tanuku Facility

Wanbury Limited secured a Good Manufacturing Practice (GMP) compliance certificate from Australia's Therapeutic Goods Administration (TGA) for its Tanuku

Wanbury Receives Australian TGA GMP Compliance Certificate for Tanuku Facility

Wanbury Ltd · Press Release · 30 Oct 2026, 6:32 pm

Wanbury Receives Australian TGA GMP Compliance Certificate for Tanuku Facility Wanbury Limited secured a Good Manufacturing Practice (GMP) compliance certificate from Australia's Therapeutic Goods Administration (TGA) for its Tanuku manufacturing facility in Andhra Pradesh. Issued on 28th Oct'26 following an inspection conducted on 8th–9th Jun'26, the certification is valid until 9th Dec'28. The approval covers six active pharmaceutical ingredients (APIs): Metformin Hydrochloride, Tramadol Hydrochloride, Sertraline Hydrochloride, Diphenhydramine Hydrochloride, Mefenamic Acid, and Paroxetine Hydrochloride Hemihydrate. The clearance enables TGA to issue GMP clearances to Australian sponsors, facilitating regulated supply into the Australian market.

Original exchange filing (PDF)

More announcements from Wanbury Ltd

All Wanbury Ltd announcements